XM does not provide services to residents of the United States of America.

BAT shares climb as first-half results fuel US optimism



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 3-BAT shares climb as first-half results fuel US optimism</title></head><body>

H1 adjusted EPS 169.3 pence vs forecast 165.91 pence

US market tough, but starting to recover share - CEO

Shares rise almost 3% to hit 10 month high

Rewrites paragraph 1 with shares; adds investor comments in 10-12; shares in 14

By Emma Rumney

LONDON, July 25 (Reuters) -British American Tobacco (BAT) BATS.L shares rose almost 3% in early Thursday trade as it beat first-half profit forecasts and investors latched on to some positives at its key U.S. business.

The maker of Lucky Strike and Dunhill cigarettes made over 40% of its revenues in the United States in 2023, mostly from tobacco, though it is also trying to grow income from smoking alternatives.

But the company has struggled in this key market as under-pressure consumers have been swapping from its more expensive cigarette brands to cheaper alternatives or e-cigarettes.

BAT's e-cigarettes have lost share to a flood of illegal disposable vapes.

Chief Executive Tadeu Marroco said it had started to recover U.S. market share, but its business and consumers remained under pressure.

"I don't expect any major shift happening in 2024," he said of U.S. consumer behaviour in a difficult economy.

The company is unlikely to meet its ambition to raise 5 billion pounds ($6.4 billion) in revenue from smoking alternatives by 2025 given the United States is a key growth driver, he said.

Tobacco investors see companies' ability to transition their businesses away from cigarettes and towards alternatives as critical amid ever-stricter regulation and falling smoking rates in some markets.

Rival Philip Morris International (PMI) PM.N is more advanced with such efforts. PMI raised its profit forecast on Tuesday, partly on expected growth in its alternative products.

While the U.S. market was still difficult for BAT, investors welcomed some green shoots.

Anthony Sedgwick, co-founder of BAT investor Abax Investments, pointed to its recovering cigarette market share and strong performance in nicotine pouches in the United States, where PMI's product currently dominates.

BAT's smoking alternatives business also became more profitable in the first half, and grew revenues ahead of expectations, said Thishan Govender, equity analyst at Truffle Asset Management, another BAT investor.

BAT posted adjusted diluted earnings for the six months to June 30 of 169.3 pence per share, against analyst expectations of 165.91 pence.

Its shares rose 2.9% to hit a 10-month high before paring gains to stand 1.9% higher at 0935 GMT.

($1 = 0.7765 pounds)



Reporting by Emma Rumney; Editing by David Goodman and Mark Potter

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.